Sepsis-Induced Cardiomyopathy: Mechanisms and Treatments

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2017 Oct 4

PMID 28970829

Citations 84

Authors

Yan-Cun Liu

Mu-Ming Yu

Song-Tao Shou

Yan-Fen Chai

Affiliations

Soon will be listed here.

Abstract

Sepsis is a lethal syndrome with a high incidence and a weighty economy burden. The pathophysiology of sepsis includes inflammation, immune dysfunction, and dysfunction of coagulation, while sepsis-induced cardiomyopathy (), defined as a global but reversible dysfunction of both sides of the heart induced by sepsis, plays a significant role in all of the aspects above in the pathogenesis of sepsis. The complex pathogenesis of involves a combination of dysregulation of inflammatory mediators, mitochondrial dysfunction, oxidative stress, disorder of calcium regulation, autonomic nervous system dysregulation, and endothelial dysfunction. The treatments for include the signal pathway intervention, Chinese traditional medicine, and other specific therapy. Here, we reviewed the latest literatures on the mechanisms and treatments of and hope to provide further insights to researchers and create a new road for the therapy of sepsis.

Citing Articles

The Cardiovascular Protective Function of Natural Compounds Through AMPK/SIRT1/PGC-1α Signaling Pathway.

Rahmani S, Roohbakhsh A, Pourbarkhordar V, Karimi G Food Sci Nutr. 2024; 12(12):9998-10009.

PMID: 39723061 PMC: 11666815. DOI: 10.1002/fsn3.4553.

Berberine ameliorates septic cardiomyopathy through protecting mitochondria and upregulating Notch1 signaling in cardiomyocytes.

Shen Q, Yuan Y, Li Z, Ling Y, Wang J, Gao M Front Pharmacol. 2024; 15:1502354.

PMID: 39568588 PMC: 11576164. DOI: 10.3389/fphar.2024.1502354.

Transcriptomics changes of calcitonin gene-related peptide in mitigating lipopolysaccharide-induced septic cardiomyopathy.

Cai K, Lin S, Gao G, Sagor M, Luo Y, Chen Z Sci Rep. 2024; 14(1):26385.

PMID: 39487252 PMC: 11530544. DOI: 10.1038/s41598-024-77520-5.

Inhibition of miR-194-5p avoids DUSP9 downregulation thus limiting sepsis-induced cardiomyopathy.

Wang J, Wei T, Zhang W, Chu Y, Zhang D, Zhang M Sci Rep. 2024; 14(1):20313.

PMID: 39218968 PMC: 11366749. DOI: 10.1038/s41598-024-71166-z.

The Impact of Extracellular Histones and Absence of Toll-like Receptors on Cardiac Functional and Electrical Disturbances in Mouse Hearts.

Loaiza R, Fattahi F, Kalbitz M, Grailer J, Russell M, Jalife J Int J Mol Sci. 2024; 25(16).

PMID: 39201339 PMC: 11354419. DOI: 10.3390/ijms25168653.

References

Xu C, Yi C, Wang H, Bruce I, Xia Q . Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening. Shock. 2011; 37(1):110-5. DOI: 10.1097/SHK.0b013e3182391831. View

Alhamdi Y, Neill D, Abrams S, Malak H, Yahya R, Barrett-Jolley R . Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection. PLoS Pathog. 2015; 11(5):e1004836. PMC: 4431880. DOI: 10.1371/journal.ppat.1004836. View

Micek S, McEvoy C, McKenzie M, Hampton N, Doherty J, Kollef M . Fluid balance and cardiac function in septic shock as predictors of hospital mortality. Crit Care. 2013; 17(5):R246. PMC: 4056694. DOI: 10.1186/cc13072. View

Gurha P . MicroRNAs in cardiovascular disease. Curr Opin Cardiol. 2016; 31(3):249-54. DOI: 10.1097/HCO.0000000000000280. View

Soriano F, Nogueira A, Caldini E, Lins M, Teixeira A, Cappi S . Potential role of poly(adenosine 5'-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Crit Care Med. 2006; 34(4):1073-9. DOI: 10.1097/01.CCM.0000206470.47721.8D. View

Gao M, Ha T, Zhang X, Wang X, Liu L, Kalbfleisch J . The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling. J Infect Dis. 2013; 207(9):1471-9. PMC: 3693590. DOI: 10.1093/infdis/jit036. View

Bohm M, Kirchmayr R, Gierschik P, Erdmann E . Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am J Med. 1995; 98(2):183-6. DOI: 10.1016/S0002-9343(99)80402-1. View

De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C . Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362(9):779-89. DOI: 10.1056/NEJMoa0907118. View

Zhang C, Mo M, Ding W, Liu W, Yan D, Deng J . High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca(2+) leak through TLR4-ROS signaling in cardiomyocytes. J Mol Cell Cardiol. 2014; 74:260-73. DOI: 10.1016/j.yjmcc.2014.06.003. View

10.

Sharshar T, Annane D, de la GrandMaison G, Brouland J, Hopkinson N, Francoise G . The neuropathology of septic shock. Brain Pathol. 2004; 14(1):21-33. PMC: 8095740. DOI: 10.1111/j.1750-3639.2004.tb00494.x. View

11.

Hoyer D, Friedrich H, Zwiener U, Pompe B, Baranowski R, Werdan K . Prognostic impact of autonomic information flow in multiple organ dysfunction syndrome patients. Int J Cardiol. 2005; 108(3):359-69. DOI: 10.1016/j.ijcard.2005.05.031. View

12.

Rudiger A, Singer M . The heart in sepsis: from basic mechanisms to clinical management. Curr Vasc Pharmacol. 2013; 11(2):187-95. View

13.

Wang H, Bei Y, Shen S, Huang P, Shi J, Zhang J . miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2. J Mol Cell Cardiol. 2016; 94:43-53. DOI: 10.1016/j.yjmcc.2016.03.014. View

14.

Opal S, Laterre P, Francois B, LaRosa S, Angus D, Mira J . Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013; 309(11):1154-62. DOI: 10.1001/jama.2013.2194. View

15.

Zhang M, Zou L, Feng Y, Chen Y, Zhou Q, Ichinose F . Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis. Anesthesiology. 2014; 121(6):1270-80. PMC: 4237617. DOI: 10.1097/ALN.0000000000000337. View

16.

Huang L, Yao Y, Dong N, Yu Y, He L, Sheng Z . Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients. Cytokine. 2010; 53(1):29-34. DOI: 10.1016/j.cyto.2010.09.010. View

17.

Zanotti-Cavazzoni S, Hollenberg S . Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care. 2009; 15(5):392-7. DOI: 10.1097/MCC.0b013e3283307a4e. View

18.

Piel D, Deutschman C, Levy R . Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis. Shock. 2008; 29(5):612-6. PMC: 3970215. DOI: 10.1097/SHK.0b013e318157e962. View

19.

Alhamdi Y, Abrams S, Cheng Z, Jing S, Su D, Liu Z . Circulating Histones Are Major Mediators of Cardiac Injury in Patients With Sepsis. Crit Care Med. 2015; 43(10):2094-103. DOI: 10.1097/CCM.0000000000001162. View

20.

Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer R . Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017; 45(3):486-552. DOI: 10.1097/CCM.0000000000002255. View